SONOMA BIOTHERAPEUTICS

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

SONOMA BIOTHERAPEUTICS

Social Links:

Industry:

Biotechnology Life Science Therapeutics

Founded:

2020-01-01

Address:

South San Francisco, California, United States

Country:

United States

Website Url:

http://www.sonomabio.com

Total Employee:

101+

Status:

Active

Total Funding:

335 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag

Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

immpact-bio-logo

ImmPACT Bio

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

kyverna-therapeutics-logo

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

opsin-biotherapeutics-logo

Opsin Biotherapeutics

Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

simcha-therapeutics-logo

Simcha Therapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Current Advisors List

rick-klausner_image

Rick Klausner Board Member @ Sonoma BioTherapeutics
Board_member
2020-02-06

Current Employees Featured

not_available_image

Leonard Dragone
Leonard Dragone Chief Medical Officer @ Sonoma BioTherapeutics
Chief Medical Officer
2020-09-01

jeffrey-bluestone_image

Jeffrey Bluestone
Jeffrey Bluestone Co-Founder ,CEO & President @ Sonoma BioTherapeutics
Co-Founder ,CEO & President
2019-10-01

heidi-m-hagen_image

Heidi M. Hagen
Heidi M. Hagen Chief Technical Officer @ Sonoma BioTherapeutics
Chief Technical Officer
2021-11-01

qizhi-tang_image

Qizhi Tang
Qizhi Tang Co-Founder & Scientific Advisor @ Sonoma BioTherapeutics
Co-Founder & Scientific Advisor

fred-ramsdell_image

Fred Ramsdell
Fred Ramsdell Co-Founder & Chief Scientific Officer @ Sonoma BioTherapeutics
Co-Founder & Chief Scientific Officer
2019-12-01

jessica-stitt_image

Jessica Stitt
Jessica Stitt Chief Financial Officer @ Sonoma BioTherapeutics
Chief Financial Officer
2022-09-01

alexander-rudensky_image

Alexander Rudensky
Alexander Rudensky Co-Founder & Scientific Advisor @ Sonoma BioTherapeutics
Co-Founder & Scientific Advisor

not_available_image

Sejal Hall
Sejal Hall Vice President, Program, Portfolio & Alliance Management @ Sonoma BioTherapeutics
Vice President, Program, Portfolio & Alliance Management
2020-09-01

susan-lacy_image

Susan Lacy
Susan Lacy Vice President Discovery @ Sonoma BioTherapeutics
Vice President Discovery
2020-09-01

Founder

alexander-rudensky_image

Alexander Rudensky

fred-ramsdell_image

Fred Ramsdell

jeffrey-bluestone_image

Jeffrey Bluestone

qizhi-tang_image

Qizhi Tang

Investors List

piper-sandler_image

Key Employee Changes

Date	New article
2022-09-07	Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer
2021-11-16	Sonoma Biotherapeutics Appoints Heidi Hagen, MBA as Chief Technical Officer
2020-09-30	Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

Official Site Inspections

http://www.sonomabio.com Semrush global rank: 1.72 M Semrush visits lastest month: 13.85 K

Host Informations
Whois Informations

Loading ...